?There are 65 million dogs and 32 million cats in the United States. Of these, roughly 6 million new cancer diagnoses are made in dogs and a similar number made in cats each year. See http://ccr.nci.nih.gov.
Let's pretend AMIC captures 1% of that market share at 1.5 doses per dogl
6,000,000 New cancers ever year (dogs only) 1% market share = 60,000 dogs treated
Avg. cost per treatment = $150 Avg wholesale per treatment = $750 Avg profit per treatment = $600
Annual Revenue for treating 1% market share (dog only) = $45 million Annual Gross Profit for treating 1% market share (dog only) = $36 million
Now wait, there's more :)
Add cats to that mix and it doubles
Annual Revenue for treating 1% market share (dogs and cats) = $90 million Annual Gross Profit for treating 1% market share (dogs and cats) = $72 million
And since it's so affordable it's not out of the question to begin estimating with the fact that Radiogel could dominate the veterinary oncology space so let's go 5% market share
Annual Revenue for treating 5% market share (dogs and cats) = $450 million Annual Gross Profit for treating 5% market share (dogs and cats) = $360 million
And now all the sudden AMIC with numbers like this is a $Billion company in the vet space ALONE.